2016
DOI: 10.5114/reum.2016.64907
|View full text |Cite
|
Sign up to set email alerts
|

Calprotectin in rheumatic diseases: a review

Abstract: Calprotectin also known as MRP8/14 or S100A8/A9 is a heterodimeric complex of two S100 calcium-binding proteins: myeloid-related protein 8 (MRP-8 or S100A8) and MRP-14 (or S100A9). At present, according to many authors, it is considered that calprotectin MRP8/14 is a potentially more sensitive biomarker of disease activity in rheumatoid disease than conventional inflammatory indices such as the erythrocyte sedimentation rate, C-reactive protein and others. A review of the literature on concentration of calprot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
46
0
8

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 47 publications
(55 citation statements)
references
References 26 publications
1
46
0
8
Order By: Relevance
“…A good correlation was also found between the concentration of calprotectin in the plasma and synovial fluid [24]. Higher concentrations of calprotectin have been detected in patients with rheumatoid arthritis compared to osteoarthritis or spondyloarthritis [24,[28][29]. Moreover, elevated levels of calprotectin have been shown in RF-positive patients than in RF-negative RA patients [29].…”
Section: Antibodies Against Carbamylated Proteins (Anti-carp)mentioning
confidence: 70%
See 4 more Smart Citations
“…A good correlation was also found between the concentration of calprotectin in the plasma and synovial fluid [24]. Higher concentrations of calprotectin have been detected in patients with rheumatoid arthritis compared to osteoarthritis or spondyloarthritis [24,[28][29]. Moreover, elevated levels of calprotectin have been shown in RF-positive patients than in RF-negative RA patients [29].…”
Section: Antibodies Against Carbamylated Proteins (Anti-carp)mentioning
confidence: 70%
“…The focus of researchers is primarily biomarkers useful for assessing disease activity and prognosis of joint damage in patients with RA. Recently, anti-carbamylated (anti-carP) antibodies and calprotectin have been described in RA, which also appears to be promising in the diagnosis of this disease [18][19][20][21][22][23][24][25][26][27][28][29][30].…”
Section: New Laboratory Biomarkers In Ramentioning
confidence: 99%
See 3 more Smart Citations